US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 37.400
  • -0.480-1.27%
Close Apr 29 16:00 ET
  • 36.290
  • -1.110-2.97%
Pre 08:57 ET
3.23BMarket Cap-8.62P/E (TTM)

CRISPR Therapeutics Key Stats

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 8.647M--
--2025/Q1-- / 5.965M--
Feb 11, 20252024/Q435.691M / 7.288M--
--2024/Q3602.000K / 7.132M--
--2024/Q2517.000K / 13.613M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 8.647M--
--2025/Q1-- / 5.965M--
Feb 11, 20252024/Q435.691M / 7.288M--
--2024/Q3602.000K / 7.132M--
--2024/Q2517.000K / 13.613M--

Unlock Free Earnings Estimates

CRISPR Therapeutics Earnings Reports

Read more

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More